FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

QS, MDR Violations at Rontis Hellas in Greece

FDA warns Greeces Rontis Hellas about Quality System and Medical Device Reporting violations in its production of a balloon catheter.

latest-news-card-1
Human Drugs

FDA Approves BMS Opdivo Qvantig Injection

FDA approves Bristol Myers Squibbs Opdivo Qvantig subcutaneous injection for several cancer indications.

Human Drugs

FDA Approves Novo Hemophilia Prophylaxis Drug

FDA approves Novo Nordisks Alhemo as a prophylaxis for some hemophilia patients.

latest-news-card-1
Human Drugs

New Sleep Apnea Indication for Lillys Zepbound

FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.

latest-news-card-1
Human Drugs

Astellas Recalls Lots of Prograf and Astagraf

FDA says Astellas has recalled one lot each of its Prograf and Astagraf transplant medications that may contain empty capsules.

latest-news-card-1
Human Drugs

Bhargava Phytolab CGMP Violations

FDA warns Indias Bhargava Phytolab about CGMP issues in its manufacturing of finished drugs and active pharmaceutical ingredients.

latest-news-card-1
Human Drugs

Axsome Plans Alzheimers NDA on Mixed Data

Axsome Therapeutics plans an NDA submission for AXS-05 (dextromethorphan-bupropion) in the second half of next year for treating Alzheimers disease ag...

latest-news-card-1
Human Drugs

Exclude Liraglutide from Compounding: Novo Nordisk

Novo Nordisk petitions FDA to exclude its liraglutide from the agencys list of bulk drug substances that may be used by drug compounders.

latest-news-card-1
Human Drugs

Mylan 6-Item Form FDA-483 Posted

FDA posts a six-item Form FDA-483 that led to a 12/19 Warning Letter to Mylan Laboratories citing its Pradesh, India manufacturing facility.

latest-news-card-1
Human Drugs

FDA Approves Checkpoints Unloxcyt

FDA approves Checkpoint Therapeutics Unloxcyt to treat some squamous cell cancer patients.